STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] PERRIGO COMPANY PLC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

State Street Corporation reported beneficial ownership of 7,340,323 shares of Perrigo Co plc common stock, representing 5.3% of the class. The filing is a Schedule 13G and shows shared voting power of 6,531,899 and shared dispositive power of 7,340,323, with no sole voting or dispositive power reported. The submission names multiple State Street advisory subsidiaries as related entities and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive
  • Material institutional stake disclosed: 7,340,323 shares representing 5.3% of Perrigo's common stock
  • Transparency and compliance: Filing is a Schedule 13G and identifies related State Street advisory subsidiaries
Negative
  • No sole control: Sole voting power and sole dispositive power are both reported as 0
  • Passive position: Certification states holdings are not for the purpose of changing or influencing control

Insights

TL;DR: State Street holds a material passive stake in Perrigo: 7.34M shares (5.3%), with shared voting influence but no sole control.

The Schedule 13G discloses a >5% institutional position, which is material from an ownership-concentration perspective. Key facts: 7,340,323 shares beneficially owned, 5.3% of the class, shared voting power 6,531,899, sole voting/dispositive power 0. The filing lists multiple State Street advisor entities as related subsidiaries, indicating the position arises from pooled/advisory accounts. Impact for investors: this increases institutional ownership concentration but the filer certifies the holding is passive.

TL;DR: The filing signals passive institutional ownership above the 5% threshold, with no declared intent to seek control.

The reporting person is identified as State Street Corporation and classified as type HC in the filing. The disclosure of shared voting power (6,531,899) and shared dispositive power (7,340,323) shows collective influence through advisory vehicles, while sole voting/dispositive powers are zero. The document includes a certification that the securities are held in the ordinary course of business and not to influence control, which is consistent with a Schedule 13G passive filing. Materiality is present due to the >5% threshold, but no governance change is indicated by the filing itself.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



STATE STREET CORPORATION
Signature:ELIZABETH SCHAEFER
Name/Title:SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
Date:08/08/2025

FAQ

How many Perrigo (PRGO) shares does State Street own?

State Street reports beneficial ownership of 7,340,323 shares of Perrigo common stock.

What percentage of PRGO does State Street own?

5.3% of the outstanding class is represented by the reported 7,340,323 shares.

Does State Street have sole voting or dispositive power over PRGO shares?

No. The filing shows 0 sole voting power and 0 sole dispositive power; voting and dispositive power are reported as shared.

What shared voting power does State Street report for PRGO?

Shared voting power of 6,531,899 shares is reported in the Schedule 13G.

Is this filing a passive disclosure or an active attempt to influence control of PRGO?

The filing includes a certification stating the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

What is the CUSIP for Perrigo's common stock referenced in the filing?

CUSIP G97822103 is provided in the Schedule 13G.
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Latest SEC Filings

PRGO Stock Data

2.05B
136.97M
0.41%
105.88%
5.38%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2